Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.440
-0.050 (-1.43%)
At close: Nov 20, 2024, 4:00 PM
3.549
+0.109 (3.18%)
After-hours: Nov 20, 2024, 5:04 PM EST
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of $651.85 million as of November 21, 2024. Its market cap has increased by 106.94% in one year.
Market Cap
651.85M
Enterprise Value
527.85M
1-Year Change
106.94%
Ranking
Category
Stock Price
$3.44
Market Cap Chart
Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $651.85M, an increase of 1,272.32%. That is a compound annual growth rate of 19.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 661.30M | 57.75% |
| Dec 29, 2023 | 419.20M | 14.98% |
| Dec 30, 2022 | 364.60M | -30.71% |
| Dec 31, 2021 | 526.20M | 74.59% |
| Dec 31, 2020 | 301.40M | 90.76% |
| Dec 31, 2019 | 158.00M | -25.65% |
| Dec 31, 2018 | 212.50M | -23.56% |
| Dec 29, 2017 | 278.00M | 106.85% |
| Dec 30, 2016 | 134.40M | -44.65% |
| Dec 31, 2015 | 242.80M | -28.19% |
| Dec 31, 2014 | 338.10M | 196.58% |
| Dec 31, 2013 | 114.00M | 89.05% |
| Dec 31, 2012 | 60.30M | 289.03% |
| Dec 30, 2011 | 15.50M | -68.04% |
| Dec 31, 2010 | 48.50M | 2.11% |
| Dec 31, 2009 | 47.50M | - |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 726.96M |
| Orthofix Medical | 698.94M |
| Dianthus Therapeutics | 698.49M |
| Adaptive Biotechnologies | 690.67M |
| InnovAge Holding | 673.21M |
| CorMedix | 661.99M |
| IRADIMED CORPORATION | 646.98M |
| agilon health | 646.87M |